| 135 | 0 | 113 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:筛选芒果苷脂质体的制备方法及最佳处方。方法:以平均粒径、聚合物分散性指数(Polydispersity index,PDI)、Zeta电位为考察指标筛选,通过L9(34)正交实验,确定芒果苷脂质体的最佳处方及制备方法。再对筛选出的最佳处方及制备方法制备出的芒果苷脂质体成品进行表征,使用高效液相色谱仪测定其包封率。结果:最佳处方:DOTAP∶胆固醇∶葵花磷脂∶芒果苷=2∶6∶1.5∶1(摩尔比),使用薄膜水合法对该脂质体制备效果最佳。成品的平均粒径为(182.20±2.25) nm,PDI为(0.148±0.001),Zeta电位为(45.70±0.56) mV。扫描电镜下芒果苷脂质体形态近圆。包封率为93.85%。结论:制备的芒果苷脂质体平均粒径较小,脂质体体系分布均匀稳定,形态近圆,符合脂质体的各项标准。
Abstract:Objective : To screen the preparation method and the optimal prescription of mangiferin liposomes. Methods : The average particle size, polydispersity index(PDI), and Zeta potential were used as evaluation indicators. The L9(34) orthogonal experiment was conducted to determine the optimal prescription and preparation method of mangiferin liposomes. The prepared mangiferin liposomes with the optimal prescription and preparation method were characterized, and the entrapment efficiency was determined by high performance liquid chromatography. Results : The optimal prescription was DOTAP∶ cholesterol∶ sunflower phospholipid∶ mangiferin = 2∶6∶1. 5∶1(molar ratio), and the film hydration method was the best for the preparation of the liposomes. The average particle size of the product was(182. 20±2. 25) nm, the PDI was(0. 148±0. 001), and the Zeta potential was(45. 70±0. 56) mV. The morphology of the mangiferin liposomes was nearly spherical under scanning electron microscopy. The entrapment efficiency was 93. 85%. Conclusion : The prepared mangiferin liposomes had a small average particle size, a uniform and stable liposome system, and a nearly spherical morphology, which met the standards of liposomes.
[1]国家药典委员会.中华人民共和国药典:一部[M].北京:中国医药科技出版社,2020.
[2]刘旭,谭丹妮,向琴,等.芒果苷对MKR小鼠肥胖症合并2型糖尿病的作用[J].中国药理学通报,2022,38(11):1639-1646.
[3]胡军峰,聂颖,徐辉甫.芒果苷通过抑制炎症、肺泡化阻滞和肺微血管受损来减轻高氧诱导的新生小鼠肺损伤[J].中国病理生理杂志,2023,39(6):1014-1020.
[4]尚影,孔维桂,江淑琴,等.芒果苷作用于COX-2和5-LOX双靶点改善良性前列腺增生炎症[J].沈阳药科大学学报,2023,40(3):309-315.
[5]张欣蕾,王晓,周子皓,等.芒果苷对急性血瘀大鼠血液流变性的影响[J].中成药,2023,45(3):944-948.
[6]卢玉翠,肖嵋方,赵立春,等.酶解结合微波提取芒果皮渣中芒果苷成分及工艺优化[J].当代化工,2023,52(9):2036-2041.
[7]冯赫宣,李佩珊,刘懿萱,等.脂质体的研究与应用进展[J].药学进展,2024,48(10):725-734.
[8]张朗朗,戴粤湘,张涵,等.鬼臼毒素脂质体的制备及其质量评价[J].中南药学,2024,22(1):65-70.
[9]颜红,宫思璠,于亮,等.脂质体作为药物载体的最新研究进展[J].药物生物技术,2023,30(3):325-330.
[10]张姝,刘俊彦.单因素方差分析法比较聚乙烯醇的聚合物分散性指数[C]//中国化学会.中国化学会第22届全国色谱学术报告会及仪器展览会论文集:第二卷.上海:中国石化上海石油化工研究院,2019:302-303.
[11]宋璇,秦迎丹,孙晨,等.不同Zeta电位纳米脂蛋白载体的物理稳定性评价[J].中国医院药学杂志,2023,43(12):1342-1346.
[12] SAMADARSI R, DUTTA D. Design and characterization of mangiferin nanoparticles for oral delivery[J]. J Food Eng, 2019,247:80-94.
[13] WANG D, WANG X, WANG L, et al. Antisense microRNA185 loaded liposome for efficient inhibition of the hepatic endogenous microRNA185 level[J]. Eur J Pharm Sci, 2021,161:105803.
[14] YAZDANI M, NIKPOOR A R, GHOLIZADEH Z, et al.Comparison of two routes of administration of a cationic liposome formulation for a prophylactic DC vaccination in a murine melanoma model[J]. Int Immunopharmacol,2021,98:107833.
[15]顾川江. NEDD4-siRNA靶向递送系统的建立和评价[D].镇江:江苏大学,2020.
[16]李玲,彭致铖,严玉晶,等.多指标权重分析法结合正交试验优选醋五灵脂炮制工艺[J].中国现代中药,2022,24(12):2455-2461.
[17]阙慧卿,彭华毅,钱丽萍,等.雷公藤内酯醇纳米脂质体的处方及制备工艺研究[J].中草药,2016,47(13):2277-2282.
[18]刘振学.实验设计与数据处理:第二版[M].北京:化学工业出版社,2015.
[19]纪刚剑,林雯,史琼枝,等.载siRNA的PLGA-bPEG纳米粒制备及初步体外评价[J].中国药业,2022,31(17):33-37.
[20]李秀楠,王海云,吴倩,等.芒果苷在扁桃叶与芒果叶中含量的比较研究[J].产业科技创新,2023,5(6):48-50.
[21]陈曼曼,杨春燕,宛云云,等. HPLC法测定知母中芒果苷的含量[J].山东化工,2022,51(12):115-119.
[22]问天娇,陈欣然,白靖,等.装载siRNA的纳米阳离子脂质体在小鼠体内的药代动力学研究[J].癌变·畸变·突变,2022,34(6):445-448.
[23]张钰婕,于晨旭,张沛敏,等.虾青素脂质体的制备及其应用研究[J].广东化工,2023,50(19):45-47.
基本信息:
DOI:
中图分类号:R943
引用信息:
[1]叶民珠,胡雨平,戴伟,等.芒果苷脂质体的制备与表征[J].赣南医科大学学报,2025,45(09):825-829.
基金信息:
国家自然科学基金国际合作项目(82111530101); 江西省杰出青年基金项目(20212ACB216002); 江西省教育厅科学技术研究项目(GJJ2201439)